Brief: Conmed Corporation Announces Second Quarter 2022 Financial Results
July 27 (Reuters) - Conmed Corp CNMD.N :
* ORATION ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS
* Q2 SALES ROSE 8.6 PERCENT TO $277.2 MILLION
* Q2 GAAP LOSS PER SHARE $5.65
* Q2 ADJUSTED EARNINGS PER SHARE $0.76
* SEES FY REVENUE $1.095 BILLION TO $1.14 BILLION
* SEES FY ADJUSTED EARNINGS PER SHARE $3.40 TO $3.55
* Q2 EARNINGS PER SHARE VIEW $0.75, REVENUE VIEW $274.2
MILLION --
REFINITIV IBES DATA
* FY2022 EARNINGS PER SHARE VIEW $3.50, REVENUE VIEW $1.12
BILLION
-- REFINITIV IBES DATA
Source text for Eikon: ID:nBw5xWZXka
Further company coverage: CNMD.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Conmed
See all newsBrief: Conmed Enters Agreements To Repurchase 2.25% Convertible Senior Notes Due 2027 On June 3 - SEC Filing
Brief: Conmed Enters First Omnibus Amendment And Increased Facility Activation Notice On May 27, 2026 - SEC Filing
Brief: Conmed Corporation Appoints Celine Martin And Jeff Mirviss To Its Board Of Directors
Medical device maker Conmed raises 2026 organic rev outlook, reaffirms EPS guidance
Brief: Micro-Tech Endoscopy To Acquire Duraclip, Precisor, And Optibite Product Lines From CONMED